3o23
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | [[Image:3o23.jpg|left|200px]] | |
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3o23", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3o23| PDB=3o23 | SCENE= }} | ||
| - | + | ===Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor=== | |
| - | Description: Human bisphosphorylated IGF1-R Kinase domain (2P) in complex with an hydantoin inhibitor | ||
| - | + | <!-- | |
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21441024}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21441024 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21441024}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | [[3o23]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O23 OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021441024</ref><references group="xtra"/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Receptor protein-tyrosine kinase]] | ||
| + | [[Category: Dupuy, A.]] | ||
| + | [[Category: Guilloteau, J P.]] | ||
| + | [[Category: Maignan, S.]] | ||
Revision as of 06:52, 4 May 2011
Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor
Template:ABSTRACT PUBMED 21441024
About this Structure
3o23 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Lesuisse D, Mauger J, Nemecek C, Maignan S, Boiziau J, Harlow G, Hittinger A, Ruf S, Strobel H, Nair A, Ritter K, Malleron JL, Dagallier A, El-Ahmad Y, Guilloteau JP, Guizani H, Bouchard H, Venot C. Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2224-8. Epub 2011 Mar 4. PMID:21441024 doi:10.1016/j.bmcl.2011.03.003
